Table 2.
Type of vascular access in use (unadjusted and risk-adjusted expected percentage) by cohort
| Incident cohorts | N | AVF/AVG, %
|
CVC, %
|
||||
|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusteda | Unadjusted | Adjusteda | ||||
| 2001 | 3623 | 23.3 | 23.9 | 76.7 | 76.1 | ||
| 2002 | 3638 | 23.4 | 23.7 | 76.6 | 76.3 | ||
| 2003 | 3698 | 22.1b | 22.7b | 77.9b | 77.3b | ||
| 2004 | 3748 | 21.0b | 21.1b | 79.0b | 78.9b | ||
| Prevalent cohorts | N | AVF, %
|
AVG, %
|
CVC, %
|
|||
|---|---|---|---|---|---|---|---|
| Unadjusted | Adjustedc | Unadjusted | Adjustedc | Unadjusted | Adjustedc | ||
| 2001 | 8239 | 46.9 | 45.6 | 11.4 | 9.0 | 41.8 | 45.4 |
| 2002 | 10585 | 47.7 | 45.0 | 10.6 | 9.0 | 41.7 | 46.0 |
| 2003 | 10384 | 43.2 | 44.7 | 7.7 | 8.9 | 49.1b | 46.4 |
| 2004 | 11084 | 41.6 | 44.5 | 6.7 | 8.9 | 51.7b | 46.6 |
a
Adjusted for age, sex, race, body mass index, late referral, smoking status, etiology of end-stage renal disease, history of diabetes, coronary artery disease, peripheral vascular disease, cerebrovascular disease, and hypertension.
b
P < 0.05 vs. 2001.
c
Adjusted for age, sex, race, body mass index, late referral, smoking status, etiology of end-stage renal disease, history of diabetes, coronary artery disease, peripheral vascular disease, cerebrovascular disease, hypertension, and dialysis vintage.